Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
(Sharecast News) - Gilead Sciences has announced it will charge developed countries $390 a vial for remdesivir, its antiviral drug currently being investigated for use in Covid-19 patients.
Read more
TOP NEWS: GlaxoSmithKline Gets First Approval For Duvroq In Japan
Read more(Sharecast News) - GlaxoSmithKline announced the approval of a Japanese New Drug Application (JNDA) by the Ministry of Health, Labour and Welfare in that country on Monday, for 'Duvroq', or daprodustat tablets.
Read more
* Wobbly session* STOXX now slightly down* U.S. futures still up* Wirecard plunges again Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves ...
Read more* Wobbly session* STOXX now slightly down* U.S. futures still up* Wirecard plunges again Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves ...
Read more* Wobbly session* STOXX now slightly down* U.S. futures still up* Wirecard plunges again Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves ...
Read more(Sharecast News) - Levels of antibodies in people who have suffered Covid-19 reportedly falls sharply in the two to three months following their infection, a study showed, although the implications for patient immunity were unclear.
Read more* STOXX erases early losses* U.S. futures firmly up* Wirecard plunges again Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves (joice.alves@...
Read more* STOXX erases early losses* U.S. futures firmly up* Wirecard plunges again Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves (joice.alves@...
Read moreUK BROKER RATINGS SUMMARY: Berenberg Downgrades Ashmore And Man Group
Read moreWelcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) i...
Read moreWelcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) i...
Read more(Repeats Friday's story with no changes to text)By Ludwig BurgerFRANKFURT, June 19 (Reuters) - There is a notable name missing from the frontrunners in the race to test experimental immunisations against the novel coronavirus: the world's largest ...
Read moreBy Ludwig BurgerFRANKFURT, June 19 (Reuters) - There is a notable name missing from the frontrunners in the race to test experimental immunisations against the novel coronavirus: the world's largest vaccine maker GlaxoSmithKline.And that is absolu...
Read moreUS Regulator Convenes Review Of GlaxoSmithKline Drug In Blood Cancer
Read more
Last checked at